New study tests personalised care to combat brain fog in Graves' disease
NCT ID NCT06309316
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tests whether a person-centred care (PCC) programme, delivered by phone and online, can help people with Graves' disease feel better mentally and return to work. 220 adults with first-time Graves' disease will be randomly assigned to receive either usual care or usual care plus PCC for 12-18 months. The main goal is to see if PCC improves self-efficacy and reduces sick leave after 3 months.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- person-centred care (PCC) via phone and web platform
- What this could lead to
- If it works, this could offer a practical, non-drug way to reduce mental fatigue and sick leave for people with Graves' disease, and may be applied to other conditions.
- What could go wrong
- This is a relatively small, early-stage trial testing a behavioural intervention, not a drug. The effect may be modest, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAVES DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Agneta Lindo
RECRUITINGGothenburg, 413 45, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Hidden thyroid cancers may be more common in Graves' disease than thought
- Can a steroid shot make thyroid surgery safer?
- Targeting the immune system: a new antibody may free Graves' patients from daily drugs
- AI reads eye scans to spot thyroid disease activity and severity
- New drug aims to tame overactive thyroid in Graves' disease
- New drug aims to tame overactive thyroid in Graves' disease